FY2028 EPS Estimates for Senseonics Lifted by HC Wainwright

Senseonics Holdings, Inc. (NYSE:SENS - Free Report) - Analysts at HC Wainwright raised their FY2028 earnings per share (EPS) estimates for shares of Senseonics in a research note issued on Monday, July 14th. HC Wainwright analyst S. Lee now expects that the company will post earnings per share of $0.00 for the year, up from their previous forecast of ($0.01). HC Wainwright currently has a "Buy" rating and a $1.40 target price on the stock. The consensus estimate for Senseonics' current full-year earnings is ($0.14) per share.

Other equities research analysts have also issued reports about the company. Wall Street Zen raised Senseonics to a "sell" rating in a research note on Monday, May 12th. Mizuho initiated coverage on Senseonics in a report on Thursday, April 10th. They issued an "outperform" rating and a $2.00 price target on the stock. Finally, TD Cowen initiated coverage on Senseonics in a report on Tuesday. They issued a "buy" rating and a $1.25 price target on the stock.

Senseonics Trading Up 1.9%

Shares of NYSE:SENS traded up $0.01 during trading on Tuesday, hitting $0.57. The company had a trading volume of 9,515,075 shares, compared to its average volume of 7,338,328. The stock has a market cap of $375.52 million, a price-to-earnings ratio of -4.42 and a beta of 0.92. Senseonics has a one year low of $0.25 and a one year high of $1.40. The company has a fifty day simple moving average of $0.52 and a two-hundred day simple moving average of $0.68. The company has a debt-to-equity ratio of 59.17, a current ratio of 2.47 and a quick ratio of 2.38.

Institutional Investors Weigh In On Senseonics

Several hedge funds and other institutional investors have recently modified their holdings of SENS. Raymond James Financial Inc. purchased a new position in Senseonics during the 4th quarter worth $26,000. IFP Advisors Inc increased its holdings in Senseonics by 120.9% during the 1st quarter. IFP Advisors Inc now owns 47,500 shares of the company's stock worth $31,000 after purchasing an additional 26,000 shares during the period. CTC Alternative Strategies Ltd. purchased a new position in Senseonics during the 1st quarter worth $31,000. HighTower Advisors LLC purchased a new position in Senseonics during the 4th quarter worth $32,000. Finally, Two Sigma Investments LP purchased a new position in Senseonics during the 4th quarter worth $36,000. 12.36% of the stock is currently owned by hedge funds and other institutional investors.

About Senseonics

Senseonics Holdings, Inc, a medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally. The company's products include Eversense, Eversense XL, and Eversense E3 that are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and a convenient app for real-time diabetes monitoring and management.